IHS Chemical Week

EnviroTech :: R&D

Pfizer Selects Prosonix Technology

11:03 AM MDT | October 6, 2008 | Deepti Ramesh

Ultrasonic process technology company Prosonix (Oxford, U.K.) says its Prosonitron reactor and sonocrystallization process technology has been selected by Pfizer for the pharma group’s active pharmaceutical ingredients (API) manufacturing facilities in Ireland. The Prosonitron technology was selected after an extended period of collaboration and testing with Pfizer’s R&D team at Sandwich, U.K., Prosonix says. The Prosonitron technology will be used in the controlled crystallization and production of a number of Pfizer products, Prosonix says. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa